Deep Reinforcement Learning for De-Novo Drug Design
We propose a novel computational strategy for de novo design of molecules with desired properties termed ReLeaSE (Reinforcement Learning for Structural Evolution). Based on deep and reinforcement learning approaches, ReLeaSE integrates two deep neural networks - generative and predictive - that are trained separately but employed jointly to generate novel targeted chemical libraries. ReLeaSE employs simple representation of molecules by their SMILES strings only. Generative models are trained with stack-augmented memory network to produce chemically feasible SMILES strings, and predictive models are derived to forecast the desired properties of the de novo generated compounds. In the first phase of the method, generative and predictive models are trained separately with a supervised learning algorithm. In the second phase, both models are trained jointly with the reinforcement learning approach to bias the generation of new chemical structures towards those with the desired physical and/or biological properties. In the proof-of-concept study, we have employed the ReLeaSE method to design chemical libraries with a bias toward structural complexity or biased toward compounds with either maximal, minimal, or specific range of physical properties such as melting point or hydrophobicity, as well as to develop novel putative inhibitors of JAK2. The approach proposed herein can find a general use for generating targeted chemical libraries of novel compounds optimized for either a single desired property or multiple properties.
Code (1)
Tasks
Deep Reinforcement LearningDrug Designreinforcement-learningReinforcement LearningReinforcement Learning (RL)Similar Papers 제목 키워드 기반
Utilizing Reinforcement Learning for de novo Drug Design
Deep learning-based approaches for generating novel drug molecules with specific properties have gained a lot of interest in the last few years. Recent studies have demonstrated promising performance for string-based gen…
DiversityDrug Designreinforcement-learningReinforcement LearningDe novo Drug Design using Reinforcement Learning with Multiple GPT Agents
De novo drug design is a pivotal issue in pharmacology and a new area of focus in AI for science research. A central challenge in this field is to generate molecules with specific properties while also producing a wide r…
DiversityDrug Designreinforcement-learningReinforcement LearningReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design
De novo drug design is a crucial component of modern drug development, yet navigating the vast chemical space to find synthetically accessible, high-affinity candidates remains a significant challenge. Reinforcement Lear…
Representation LearningReinforcement LearningWidely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model
De novo molecular design has facilitated the exploration of large chemical space to accelerate drug discovery. Structure-based de novo method can overcome the data scarcity of active ligands by incorporating drug-target …
Drug DesignDrug DiscoveryMolecular DockingReinforcement Learning (RL)Reinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective
Many multi-genic systemic diseases such as neurological disorders, inflammatory diseases, and the majority of cancers do not have effective treatments yet. Reinforcement learning powered systems pharmacology is a potenti…
Drug DesignDrug Discoveryreinforcement-learningReinforcement Learning+1